Hsbc Holdings PLC lessened its holdings in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 77.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,248 shares of the company's stock after selling 36,217 shares during the quarter. Hsbc Holdings PLC's holdings in Astera Labs were worth $605,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Hoey Investments Inc. increased its holdings in Astera Labs by 4.2% in the 1st quarter. Hoey Investments Inc. now owns 5,000 shares of the company's stock valued at $298,000 after buying an additional 200 shares during the period. Sound Income Strategies LLC increased its holdings in Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after buying an additional 204 shares during the period. Allworth Financial LP increased its holdings in Astera Labs by 20.4% in the 1st quarter. Allworth Financial LP now owns 1,394 shares of the company's stock valued at $90,000 after buying an additional 236 shares during the period. GAMMA Investing LLC grew its holdings in shares of Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after purchasing an additional 284 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC grew its holdings in shares of Astera Labs by 1.1% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 28,939 shares of the company's stock worth $1,727,000 after purchasing an additional 320 shares during the last quarter. Institutional investors own 60.47% of the company's stock.
Insider Buying and Selling at Astera Labs
In related news, COO Sanjay Gajendra sold 91,441 shares of the stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief operating officer directly owned 2,170,877 shares of the company's stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Michael Truett Tate sold 18,861 shares of the stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $3,461,182.11. Following the sale, the chief financial officer directly owned 259,512 shares of the company's stock, valued at approximately $47,623,047.12. The trade was a 6.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,649,489 shares of company stock worth $232,463,986 in the last quarter. Company insiders own 12.50% of the company's stock.
Astera Labs Trading Up 4.5%
Shares of NASDAQ:ALAB traded up $8.02 during mid-day trading on Thursday, reaching $184.63. The stock had a trading volume of 2,403,817 shares, compared to its average volume of 4,907,777. The firm has a market cap of $30.69 billion, a PE ratio of 331.33, a price-to-earnings-growth ratio of 4.62 and a beta of 1.48. The firm has a 50 day simple moving average of $137.83 and a two-hundred day simple moving average of $97.51. Astera Labs, Inc. has a twelve month low of $36.85 and a twelve month high of $199.47.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same period last year, the company posted $0.13 EPS. Astera Labs's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.
Analyst Ratings Changes
Several research firms have recently weighed in on ALAB. Susquehanna upped their target price on shares of Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a report on Thursday, August 7th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a report on Tuesday. Northland Capmk downgraded shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. Wall Street Zen upgraded shares of Astera Labs from a "hold" rating to a "buy" rating in a research report on Saturday, August 16th. Finally, CICC Research started coverage on shares of Astera Labs in a research report on Friday, August 29th. They set an "outperform" rating and a $190.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Astera Labs currently has a consensus rating of "Moderate Buy" and a consensus target price of $142.00.
Read Our Latest Stock Analysis on ALAB
Astera Labs Company Profile
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also

Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.